メタ情報
| meta description平均長 | 170.25 | 
|---|
| OGPありページ数 | 12 | 
|---|
| Twitterカードありページ数 | 1 | 
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 34 | 
|---|
| ページあたり内部リンク平均 | 46.46 | 
|---|
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み | 
|---|
| ASA | 1 | 
| University | 0.976768 | 
| research | 0.951613 | 
| Hosted | 0.799174 | 
| patients | 0.646684 | 
| has | 0.567092 | 
| syndrome | 0.543011 | 
| EEG | 0.532782 | 
| related | 0.532782 | 
| have | 0.527296 | 
| projects | 0.497449 | 
| therapeutic | 0.497449 | 
| will | 0.452123 | 
| members | 0.444588 | 
| board | 0.443985 | 
| brain | 0.443985 | 
| his | 0.443985 | 
| neurons | 0.443985 | 
| CAB | 0.443985 | 
| disorder | 0.427806 | 
| Board | 0.358163 | 
| you | 0.358163 | 
| role | 0.358163 | 
| work | 0.358163 | 
| molecular | 0.358163 | 
| Advisory | 0.355188 | 
| approach | 0.355188 | 
| become | 0.355188 | 
| member | 0.355188 | 
| there | 0.355188 | 
| parent | 0.355188 | 
| Research | 0.355188 | 
| They | 0.355188 | 
| methods | 0.355188 | 
| models | 0.355188 | 
| well | 0.355188 | 
| studies | 0.355188 | 
| basis | 0.355188 | 
| mechanisms | 0.355188 | 
| She | 0.355188 | 
| clinical | 0.355188 | 
| characteristic | 0.355188 | 
| USA | 0.355188 | 
| received | 0.355188 | 
| disorders | 0.355188 | 
| Alliance | 0.333333 | 
| genetic | 0.298469 | 
| funded | 0.28852 | 
| ANGELMAN | 0.28852 | 
| stem | 0.28852 | 
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 | 
|---|
| Angelman | Syndrome | 4.424266 | 857 | 
| announce | excited | 4.010722 | 88 | 
| changes | lasting | 4.00957 | 84 | 
| induced | pluripotent | 3.770611 | 60 | 
| demeanour | happy | 3.770611 | 60 | 
| DUB | enzymes | 3.712631 | 56 | 
| Basque | Country | 3.712631 | 56 | 
| diseases | neurodegenerative | 3.712631 | 56 | 
| Clayton | Smith | 3.712631 | 56 | 
| advocates | patient | 3.712631 | 56 | 
| create | fundamental | 3.66155 | 56 | 
| States | United | 3.577644 | 56 | 
| publication | second | 3.478607 | 60 | 
| available | now | 3.478607 | 60 | 
| Human | available | 3.478607 | 60 | 
| Cell | Human | 3.478607 | 60 | 
| parallel | studies | 3.455333 | 63 | 
| discuss | latest | 3.444864 | 52 | 
| Cell | study | 3.444715 | 60 | 
| issues | related | 3.441311 | 84 | 
| cerebellar | dysfunction | 3.412434 | 56 | 
| ERASMUS | Neuroscience | 3.412434 | 56 | 
| inhibitor | peptide | 3.412434 | 56 | 
| biomedical | pharmaceutical | 3.412434 | 56 | 
| advocates | expert | 3.412434 | 56 | 
| difficulties | learning | 3.412434 | 56 | 
| New | York | 3.385763 | 49 | 
| Member | duties | 3.380215 | 35 | 
| causes | severe | 3.377991 | 56 | 
| Advisory | Board | 3.375249 | 88 | 
| fundamental | lasting | 3.361353 | 56 | 
| mechanisms | molecular | 3.323963 | 84 | 
| InnovAS | goal | 3.299533 | 35 | 
| Center | UNC | 3.299533 | 35 | 
| pluripotent | stem | 3.267983 | 60 | 
| Board | Scientific | 3.238175 | 77 | 
| Hamburg | Meeting | 3.237315 | 32 | 
| across | representatives | 3.237315 | 32 | 
| beyond | reflect | 3.237315 | 32 | 
| ahead | plan | 3.237315 | 32 | 
| PHASE | SYNDROME | 3.237315 | 32 | 
| PHASE | TRIALS | 3.237315 | 32 | 
| COMMUNITY | TRIALS | 3.237315 | 32 | 
| COMMUNITY | UPDATE | 3.237315 | 32 | 
| UPDATE | Webinar | 3.237315 | 32 | 
| Webinar | recorded | 3.237315 | 32 | 
| TenTbLp | youtu | 3.237315 | 32 | 
| TenTbLp | pIk | 3.237315 | 32 | 
| WHO | pIk | 3.237315 | 32 | 
| HOSTED | WHO | 3.237315 | 32 | 
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録